Moving into an in vivo study is a significant development milestone, but the right timing depends on more than completing benchtop work. This brief introduces a six-gate review to help medical device teams assess whether the device, procedure, model, and study objectives are sufficiently defined to generate meaningful evidence.

This Expert Brief was developed with input from medical device regulatory strategy expert Sam Gilbert, VMD, following the webinar Regulatory Strategy for Medical Device Preclinical Programs.